☰

Victoria Auerbuch, Ph.D. - Publications

Affiliations: 
2002 University of California, Berkeley, Berkeley, CA, United States 
Area:
Molecular and cellular basis of microbial pathogenesis
Tree Info Grants Similar researchers PubMed Report error

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Schubert KA, Xu Y, Shao F, Auerbuch V. The Type III Secretion System as a Tool for Studying Cytosolic Innate Immune Surveillance. Annual Review of Microbiology. PMID 32660389 DOI: 10.1146/Annurev-Micro-020518-120221  0.446
2019 Hooker-Romero D, Mettert E, Schwiesow L, Balderas D, Alvarez PA, Kicin A, Gonzalez AL, Plano GV, Kiley PJ, Auerbuch V. Iron availability and oxygen tension regulate the Yersinia Ysc type III secretion system to enable disseminated infection. Plos Pathogens. 15: e1008001. PMID 31869388 DOI: 10.1371/Journal.Ppat.1008001  0.336
2019 Hooker-Romero D, Schwiesow L, Wei Y, Auerbuch V. Mouse Models of Yersiniosis. Methods in Molecular Biology (Clifton, N.J.). 2010: 41-53. PMID 31177430 DOI: 10.1007/978-1-4939-9541-7_4  0.331
2019 Francis MS, Auerbuch V. Editorial: The Pathogenic Yersiniae-Advances in the Understanding of Physiology and Virulence, Second Edition. Frontiers in Cellular and Infection Microbiology. 9: 119. PMID 31058103 DOI: 10.3389/Fcimb.2019.00119  0.324
2018 Morgan JM, Lam HN, Delgado J, Luu J, Mohammadi S, Isberg RR, Wang H, Auerbuch V. An Experimental Pipeline for Initial Characterization of Bacterial Type III Secretion System Inhibitor Mode of Action Using Enteropathogenic . Frontiers in Cellular and Infection Microbiology. 8: 404. PMID 30524970 DOI: 10.3389/Fcimb.2018.00404  0.374
2017 Lam H, Schwochert J, Lao Y, Lau T, Lloyd C, Luu J, Kooner O, Morgan J, Lokey S, Auerbuch V. Synthetic cyclic peptomers as type III secretion system inhibitors. Antimicrobial Agents and Chemotherapy. PMID 28652236 DOI: 10.1128/Aac.00060-17  0.387
2017 Duncan MC, Herrera NG, Johnson KS, Engel JN, Auerbuch V. Bacterial internalization is required to trigger NIK-dependent NF-κB activation in response to the bacterial type three secretion system. Plos One. 12: e0171406. PMID 28166267 DOI: 10.1371/Journal.Pone.0171406  0.408
2016 Auerbuch V. The Type III Secretion System Cleans up Its Act(in). Cell Host & Microbe. 20: 275-6. PMID 27631695 DOI: 10.1016/J.Chom.2016.08.012  0.431
2016 Miller HK, Schwiesow L, Au-Yeung W, Auerbuch V. Hereditary Hemochromatosis Predisposes Mice to Yersinia pseudotuberculosis Infection Even in the Absence of the Type III Secretion System. Frontiers in Cellular and Infection Microbiology. 6: 69. PMID 27446816 DOI: 10.3389/Fcimb.2016.00069  0.405
2015 Schwiesow L, Lam H, Dersch P, Auerbuch V. The Yersinia type III secretion system master regulator LcrF. Journal of Bacteriology. PMID 26644429 DOI: 10.1128/Jb.00686-15  0.372
2015 Adams W, Morgan J, Kwuan L, Auerbuch V. Yersinia pseudotuberculosis YopD mutants that genetically separate effector protein translocation from host membrane disruption. Molecular Microbiology. 96: 764-78. PMID 25684661 DOI: 10.1111/Mmi.12970  0.445
2014 Miller HK, Kwuan L, Schwiesow L, Bernick DL, Mettert E, Ramirez HA, Ragle JM, Chan PP, Kiley PJ, Lowe TM, Auerbuch V. IscR is essential for yersinia pseudotuberculosis type III secretion and virulence. Plos Pathogens. 10: e1004194. PMID 24945271 DOI: 10.1371/Journal.Ppat.1004194  0.407
2014 Duncan MC, Wong WR, Dupzyk AJ, Bray WM, Linington RG, Auerbuch V. An NF-κB-based high-throughput screen identifies piericidins as inhibitors of the Yersinia pseudotuberculosis type III secretion system. Antimicrobial Agents and Chemotherapy. 58: 1118-26. PMID 24295981 DOI: 10.1128/Aac.02025-13  0.356
2013 Kwuan L, Adams W, Auerbuch V. Impact of host membrane pore formation by the Yersinia pseudotuberculosis type III secretion system on the macrophage innate immune response. Infection and Immunity. 81: 905-14. PMID 23297383 DOI: 10.1128/Iai.01014-12  0.459
2012 Duncan MC, Linington RG, Auerbuch V. Chemical inhibitors of the type three secretion system: disarming bacterial pathogens. Antimicrobial Agents and Chemotherapy. 56: 5433-41. PMID 22850518 DOI: 10.1128/Aac.00975-12  0.393
2009 Auerbuch V, Golenbock DT, Isberg RR. Innate immune recognition of Yersinia pseudotuberculosis type III secretion. Plos Pathogens. 5: e1000686. PMID 19997504 DOI: 10.1371/Journal.Ppat.1000686  0.462
2007 Auerbuch V, Isberg RR. Growth of Yersinia pseudotuberculosis in mice occurs independently of Toll-like receptor 2 expression and induction of interleukin-10. Infection and Immunity. 75: 3561-70. PMID 17420232 DOI: 10.1128/Iai.01497-06  0.414
2007 Herskovits AA, Auerbuch V, Portnoy DA. Bacterial ligands generated in a phagosome are targets of the cytosolic innate immune system. Plos Pathogens. 3: e51. PMID 17397264 DOI: 10.1371/Journal.Ppat.0030051  0.615
2004 Auerbuch V, Brockstedt DG, Meyer-Morse N, O'Riordan M, Portnoy DA. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. The Journal of Experimental Medicine. 200: 527-33. PMID 15302899 DOI: 10.1084/Jem.20040976  0.634
2003 Auerbuch V, Loureiro JJ, Gertler FB, Theriot JA, Portnoy DA. Ena/VASP proteins contribute to Listeria monocytogenes pathogenesis by controlling temporal and spatial persistence of bacterial actin-based motility. Molecular Microbiology. 49: 1361-75. PMID 12940993 DOI: 10.1046/J.1365-2958.2003.03639.X  0.613
2002 Portnoy DA, Auerbuch V, Glomski IJ. The cell biology of Listeria monocytogenes infection: the intersection of bacterial pathogenesis and cell-mediated immunity. The Journal of Cell Biology. 158: 409-14. PMID 12163465 DOI: 10.1083/Jcb.200205009  0.704
2002 Auerbuch V, Portnoy DA. Microbial pathogenesis and the eukaryotic cytoskeleton at the American Society for Cell Biology annual meeting. Cellular Microbiology. 4: 187-90. PMID 11906455 DOI: 10.1046/J.1462-5822.2002.00187.X  0.54
2001 Skoble J, Auerbuch V, Goley ED, Welch MD, Portnoy DA. Pivotal role of VASP in Arp2/3 complex-mediated actin nucleation, actin branch-formation, and Listeria monocytogenes motility. The Journal of Cell Biology. 155: 89-100. PMID 11581288 DOI: 10.1083/Jcb.200106061  0.667
2001 Auerbuch V, Lenz LL, Portnoy DA. Development of a competitive index assay to evaluate the virulence of Listeria monocytogenes actA mutants during primary and secondary infection of mice. Infection and Immunity. 69: 5953-7. PMID 11500481 DOI: 10.1128/Iai.69.9.5953-5957.2001  0.556
1999 Moors MA, Auerbuch V, Portnoy DA. Stability of the Listeria monocytogenes ActA protein in mammalian cells is regulated by the N-end rule pathway. Cellular Microbiology. 1: 249-57. PMID 11207557 DOI: 10.1046/J.1462-5822.1999.00020.X  0.593
Show low-probability matches.